New Products and Devices
New products and pharmacologic developments
New Skincare Line from Envy Medical
Envy Medical introduced a new range of skincare, formulated to address age-related concerns including hyperpigmentation, dullness, sagging skin, and fine lines.
The Envy Medical range is segmented into four offerings that target byproducts of aging: Daily Skin Health Maintenance, Skin Brightening, Intensive Skin Brightening, and Skin Brightening & Renewal, with products from each intended to work together for optimal results, based on individual skincare goals. The collection uses patented ingredient technologies, including Envy Medical’s exclusive Lumixyl Peptide. While products are formulated to be integrated to a complete skincare routine, they’re also ideal complements to Envy Medical’s signature professional treatment, Dermalinfusion. This 3-in-1 professional exfoliation treatment eliminates dulling surface matter like dead skin cells, removes it from the epidermis, and infuses skin with a specific serum that addresses dehydration, dullness, uneven skin texture and tone, and blemished skin. This patented treatment is recommended for all skin types and can be used on most areas of the body, with few contraindications, resulting in more radiant skin, a stimulation in cellular turnover, plumper skin (by 70%), and more. Envymedical.com
TriXera Nutrition Line Now Available from Eau Thermal Avéne
Eau Thermal Avéne has a new advanced skincare line formulated to nourish and hydrate dry to very dry sensitive skin. The new TriXera Nutrition range for face and body include Nutri-fluid Cleansers, Nutri-fluid Lotion, and Nutri-fluid Balm. All three products are hypoallergence and non-comedogenic and infused with Selectiose, a patented ingredient sustainably sourced from a sugar, and a nourishing, plant-based Lipid Trio to limit water loss and restore and strengthen the skin barrier. The Nutri-fluid texture allows each formula to glide on and melt on contact with the skin with a cool, light touch to provide immediate relief from dry skin symptoms. The Balm is fragrance free, but the Lotion and Cleanser are scented with a fresh fragrance well tolerated by sensitive skin, according to the company. Aveneusa.com
SkinCeuticals Discoloration Defense
With Discoloration Defense, SkinCeuticals introduces a treatment to help prevent and correct against all types of discoloration, including stubborn brown patches. Boasting a potent combination of key ingredients, 3% tranexamic acid, 5% niacinimide, 1% kojic acid, and 5% HEPES (a sulfonic acid), the serum provides a measurable reduction in visible and stubborn pigmentation for a revitalized and even complexion, with refined texture and clarity. These ingredients work together to help break up existing melanin clusters, inhibit the formation of melanocytes and deactivate inflammatory mediators, which has been newly established as a key factor in pigmentation. The product will be available beginning in February. SkinCeuticals.com
Carpe Offers OTC SOlution for Excess Sweat
When two college roommates commiserated about their sweaty hands and feet, they decided they would have to find a solution themselves. Hence, they turned their dorm room into a lab, and eventually Carpe lotion was born. The developers note that hyperhidrosis remains under-recognized, and many of those affected try to cope through unsuccessful strategies.To address this frustration, the developers say they seek to bring “prescription level efficacy to OTC access.”
Carpe lotion is designed to manage excess sweat with a smooth formulation that has no greasy feel. According to Carpe co-founder David Spratte, the formulation was developed to reduce sweat without over-drying the skin.
Carpe is formulated to cause no irritation or residue. The product should be applied nightly for optimal effect. It is available on Amazon.com and through Carpelotion.com
Therapeutic Focus: Devices
Allergan’s CoolSculpting Treatment Now FDA Approved to Improve Appearance of Lax Tissue in Double Chin
The FDA approved Allergan plc’s CoolSculpting treatment for improved appearance of lax tissue in conjunction with submental fat, or double chin, treatments. CoolSculpting for the double chin is already clinically proven to reduce fat up to 20 percent in the treated area after one treatment.
An 18-week clinical study of CoolSculpting in submental fat treatment found that 77 percent of patients showed improved appearance of lax tissue and 75 percent of patients reported their chin looked more toned following treatment.
“In my own patients, I have noticed the improved appearance of lax tissue when using the CoolMini applicator for the CoolSculpting system to treat the submental area,” said Jeffrey S. Dover, MD, FRCPC, Co-Director of SkinCare Physicians of Chestnut Hill, Mass. “It is great to see the company invest to validate this and secure the FDA clearance.”
Restoration Names New CFO
Restoration Robotics, Inc. will have a new Chief Financial Officer next year. Industry veteran Mark L. Hair took over th role as of January 5, 2018. Mr. Hair brings with him over 20 years of executive management, financial advisory, consulting, and public company experience.
Ryan Rhodes, Chief Executive Officer of Restoration Robotics, said, “I am extremely pleased to welcome Mark and to add such an experienced executive to our team as we continue to expand our US and international sales and distribution infrastructure, enhance our marketing initiatives, drive incremental regulatory approvals, and further invest in new and existing R&D initiatives to support future growth. Mark’s executive leadership and corporate finance experience in the medical device space, and specifically within the aesthetics space at ZELTIQ, make him well equipped to help guide Restoration Robotics through this period of commercial expansion as a public company. I am confident that his contributions will be vital in executing our near and long term corporate initiatives.”
Can At-Home Light Therapy Device Help Patients Reduce Wrinkles?
BioPhotas, Inc. launched its Celluma HOME, a fourth model in the Celluma Series of light therapy devices. The company says the Celluma HOME specifically addresses the challenges of Baby Boomers who struggle with wrinkles, aches, and pain. FDA-cleared for over-the-counter purchase, the company notes the Celluma HOME, available at an introductory price of $599, treats eight separate aging challenges faced by the Baby Boomer, including full face wrinkles, arthritis, muscle and joint pain, muscle spasms, and poor blood circulation.
Patrick Johnson, President & Chief Executive Officer for BioPhotas said, “From the very start, our goal at BioPhotas was to bring an FDA-cleared medical device directly to the consumer at home with the efficacy of large professional panels, but with the affordability of small hand-held devices. We believe we have achieved this with the Celluma HOME. Designed to treat a wide range of skin, muscle, and joint conditions, anywhere on the body, the Celluma HOME gives the consumer the benefit of multiple hand-held devices in a single light panel with a significantly larger in treatment area.”
The Celluma HOME delivers blue, red, and near-infrared light energy to safely address a wide variety of musculoskeletal and dermatological conditions. Each wavelength is absorbed by different molecules, which act as a signaling mechanism for different cellular processes. With a treatment area that measures 14" by 6", the Celluma HOME is several times larger than typical hand-held light therapy devices. The Celluma’s patented shape-taking light panel facilitates effective energy absorption by tissue by molding closely to any apart of the body, producing more efficient outcomes.
The Celluma Series of light therapy devices is protected by both US and Foreign utility patents and is CE-marked as a Dermal Wound Healing device.
Skin Rejuvenation Market: Laser Based Devices to Grow at 9.7% CAGR During 2017-2022
According to the research report “Skin Rejuvenation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” by Persistence Market Research the global market for skin rejuvenation is projected to register a healthy CAGR of 8.7% throughout the period of assessment to reflect a noteworthy market value.
By product type, the global skin rejuvenation market is dominated by IPL devices segment, and by product type category, the laser-based devices market is the fastest growing segment to reach stellar valuation. This segment is rising owing to increased use of laser in skin rejuvenation treatment procedures.
By end user category, the dermatology clinics segment is the largest segment and is likely to lead the global skin rejuvenation market in terms of market valuation. In 2017, this segment reflected a high market share of more than 60 percent and is likely to continue to retain its status quo during the assessment period 2017-2022.
The Viability of Phototherapy: Where does phototherapy fit into the current treatment options for psoriasis?
The excellent safety profile of phototherapy makes it a viable treatment option for many patients with psoriasis, even in an age of biologics, says Elma Baron, MD. Efficacy of phototherapy is high, she says.
Laser Research Optics Introduces New Line of Medical CO2 Optics for Tattoo Removal Lasers
Laser Research Optics has introduced a line of OEM quality, laser-grade ZnSe optics that can be supplied in a variety of configurations for various types of tattoo removal lasers.
Laser Research Medical CO2 Laser Optics are optimized for 1064 nm and 1.06 µm for Nd:yag lasers used for tattoo removal and other dermatology procedures. Ideally suited for laser equipment OEMs, they are offered as ZnSe plano-convex and plane-parallel discs, output couplers, and mirrors manufactured to specification in 1/2" and 3/4" O.D. sizes.
Available with dual-band and reflectance coatings up to 95 percent on each side, Laser Research Medical CO2 Laser Optics feature 40-20 scratch-dig surface finishes per MIL-O-13830 (20-10 one face on plane-parallel) and 1/4th wave at HeNe flatness and surface accuracy at 10.6 microns, with 3 arc-minutes maximum parallelism.
Laser Research Medical CO2 Laser Optics are priced according to configuration and quantity. Price quotations are available upon request.
Treating Atrophic Striae: Percutaneous Collagen Induction Therapy vs Fractional Nonablative Laser
As atrophic striae are common dermatological conditions that pose a considerable challenge in terms of assessment and treatment. Many therapeutic modalities have already been employed without treatment of striae distensae, a majority related to striae rubra, with few studies that included striae alba alone.
The non-ablative fractionated laser and, more recently, microneedling are two distinct treatments widely used in dermatologist practices.
A randomized clinical trial is being conducted to evaluate the response of microneedle and fractional non-ablative laser Nd-yap 1340 in the treatment of abdominal striae alba.
Twenty patients will be treated at the dermatology outpatient clinic of the Hospital de Clínicas de Porto Alegre (HCPA). Each patient will be treated at five sessions at monthly intervals with laser and microneedle at the same time in the abdomen (divided lengthwise and in equal parts). Each part of the abdomen will be randomized for the treatment of laser or microneedling with the help of the Excel 2013 program. ND-yap 1340-nm laser will be used, and in the other segment of the abdomen, the dermaroller 2.5 mm applied. Photographic records of patients will be performed at pre-treatment and one month after the third and fifth sessions. Questionnaires will be applied to assess the quality of life in dermatology DLQI (Dermatology Life Quality Index). Two independent and blinded evaluators will apply the Global Aesthetic Scale (GAIS) in the evaluation of photographic records. Cutaneous biopsies for histopathological evaluation will be performed with a punch 3mm of each part of the abdomen at pretreatment. Pathologists will evaluate the measurements of the epidermis and the collagen and elastic fibers of the skin.